D-0336-2018 Class II Terminated
FDA drug recall D-0336-2018 was initiated by Glenmark Pharmaceuticals Inc., USA on Nov 20, 2017 and is designated Class II. Reason for recall: CGMP Deviations: Market complaints related to "gritty texture". The recall status is terminated (terminated Oct 3, 2018). Affected quantity: 5136 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2018
- Initiation Date
- Nov 20, 2017
- Termination Date
- Oct 3, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5136 tubes
Product description
Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 NDC 68462019255 UPC 3684620192559
Reason for recall
CGMP Deviations: Market complaints related to "gritty texture".
Distribution pattern
Product was distributed throughout the United States.
Code information
Batch Number: 05170598; Exp. 03/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0336-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026